Company Announcements

Statement re CMA Final Determinations

Source: RNS
RNS Number : 4990Q
28 October 2021

SSE plc

CMA Final Determinations

28 October 2021


The CMA has today published a summary of its final determinations into SSEN Transmission's appeal against certain elements of Ofgem's RIIO-T2 price control settlement.  The full final determinations and associated documents are expected to be provided to appellants and interveners later this week and then published by the CMA shortly thereafter.

SSEN Transmission welcomes that the CMA has upheld its appeals against the assumed 'Outperformance Wedge', and for changes to the Licence Modification Process.

However, SSEN Transmission is disappointed that the CMA has not upheld its appeals on the flawed Cost of Equity, or on changes to how Transmission Network Use of System Charges are recovered and the associated risk of under recovery this presents.

SSEN Transmission will continue to assess the full details of the CMA's final determinations as they become available and remains committed to work constructively with Ofgem and wider stakeholders as it continues to take forward ambitious plans to deliver a network for net zero.  


Investors and Analysts                     +44(0)345 0760 530

Media                                      +44(0)345 0760 530                                                      


SSEN Transmission, operating under licence held by Scottish Hydro Electric (SHE) Transmission plc, owns, operates and develops the high voltage electricity transmission system in the north of Scotland and remote islands. 

SSEN Transmission is a wholly owned subsidiary of SSE plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.